These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

591 related articles for article (PubMed ID: 32941808)

  • 21. STAT3 is activated by JAK2 independent of key oncogenic driver mutations in non-small cell lung carcinoma.
    Looyenga BD; Hutchings D; Cherni I; Kingsley C; Weiss GJ; Mackeigan JP
    PLoS One; 2012; 7(2):e30820. PubMed ID: 22319590
    [TBL] [Abstract][Full Text] [Related]  

  • 22. JAK2/STAT3 signaling pathway activation mediates tumor angiogenesis by upregulation of VEGF and bFGF in non-small-cell lung cancer.
    Zhao M; Gao FH; Wang JY; Liu F; Yuan HH; Zhang WY; Jiang B
    Lung Cancer; 2011 Sep; 73(3):366-74. PubMed ID: 21333372
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The interleukin-6-type cytokine oncostatin M induces aryl hydrocarbon receptor expression in a STAT3-dependent manner in human HepG2 hepatoma cells.
    Stobbe-Maicherski N; Wolff S; Wolff C; Abel J; Sydlik U; Frauenstein K; Haarmann-Stemmann T
    FEBS J; 2013 Dec; 280(24):6681-90. PubMed ID: 24127753
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression and the potential functions of TRIM32 in lung cancer tumorigenesis.
    Yin H; Li Z; Chen J; Hu X
    J Cell Biochem; 2019 Apr; 120(4):5232-5243. PubMed ID: 30378152
    [TBL] [Abstract][Full Text] [Related]  

  • 25. PYCR1 knockdown inhibits the proliferation, migration, and invasion by affecting JAK/STAT signaling pathway in lung adenocarcinoma.
    Gao Y; Luo L; Xie Y; Zhao Y; Yao J; Liu X
    Mol Carcinog; 2020 May; 59(5):503-511. PubMed ID: 32133692
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Upregulation of CXCR4 is functionally crucial for maintenance of stemness in drug-resistant non-small cell lung cancer cells.
    Jung MJ; Rho JK; Kim YM; Jung JE; Jin YB; Ko YG; Lee JS; Lee SJ; Lee JC; Park MJ
    Oncogene; 2013 Jan; 32(2):209-21. PubMed ID: 22370645
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The membrane bile acid receptor TGR5 drives cell growth and migration via activation of the JAK2/STAT3 signaling pathway in non-small cell lung cancer.
    Liu X; Chen B; You W; Xue S; Qin H; Jiang H
    Cancer Lett; 2018 Jan; 412():194-207. PubMed ID: 29074425
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aryl Hydrocarbon Receptor: Its Regulation and Roles in Transformation and Tumorigenesis.
    Che X; Dai W
    Curr Drug Targets; 2019; 20(6):625-634. PubMed ID: 30411679
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HES5 promotes cellular proliferation of non-small cell lung cancer through STAT3 signaling.
    Gu S; Zhang R; Gu J; Li X; Lv L; Jiang J; Xu Z; Wang S; Shi C; Wang DP; Wu C
    Oncol Rep; 2017 Jan; 37(1):474-482. PubMed ID: 27878283
    [TBL] [Abstract][Full Text] [Related]  

  • 30. AhR ligand Aminoflavone inhibits α6-integrin expression and breast cancer sphere-initiating capacity.
    Brantley E; Callero MA; Berardi DE; Campbell P; Rowland L; Zylstra D; Amis L; Yee M; Simian M; Todaro L; Loaiza-Perez AI; Soto U
    Cancer Lett; 2016 Jun; 376(1):53-61. PubMed ID: 26996297
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PRMT5-mediated methylation of STAT3 is required for lung cancer stem cell maintenance and tumour growth.
    Abe Y; Sano T; Otsuka N; Ogawa M; Tanaka N
    Commun Biol; 2024 May; 7(1):593. PubMed ID: 38760429
    [TBL] [Abstract][Full Text] [Related]  

  • 32. EML4-ALK-mediated activation of the JAK2-STAT pathway is critical for non-small cell lung cancer transformation.
    Li Y; Li Y; Zhang H; Shi R; Zhang Z; Liu H; Chen J
    BMC Pulm Med; 2021 Jun; 21(1):190. PubMed ID: 34090412
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Aryl hydrocarbon receptor activation and overexpression upregulated fibroblast growth factor-9 in human lung adenocarcinomas.
    Wang CK; Chang H; Chen PH; Chang JT; Kuo YC; Ko JL; Lin P
    Int J Cancer; 2009 Aug; 125(4):807-15. PubMed ID: 19358281
    [TBL] [Abstract][Full Text] [Related]  

  • 34. miR-210 transferred by lung cancer cell-derived exosomes may act as proangiogenic factor in cancer-associated fibroblasts by modulating JAK2/STAT3 pathway.
    Fan J; Xu G; Chang Z; Zhu L; Yao J
    Clin Sci (Lond); 2020 Apr; 134(7):807-825. PubMed ID: 32219336
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Induction of aryl hydrocarbon receptor in granulosa cells by endoplasmic reticulum stress contributes to pathology of polycystic ovary syndrome.
    Kunitomi C; Harada M; Kusamoto A; Azhary JM; Nose E; Koike H; Xu Z; Urata Y; Takahashi N; Wada-Hiraike O; Hirota Y; Koga K; Fujii T; Osuga Y
    Mol Hum Reprod; 2021 Feb; 27(3):. PubMed ID: 33493289
    [TBL] [Abstract][Full Text] [Related]  

  • 36. LncRNA SNHG3 is activated by E2F1 and promotes proliferation and migration of non-small-cell lung cancer cells through activating TGF-β pathway and IL-6/JAK2/STAT3 pathway.
    Shi J; Li J; Yang S; Hu X; Chen J; Feng J; Shi T; He Y; Mei Z; He W; Xie J; Li S; Jie Z; Tu S
    J Cell Physiol; 2020 Mar; 235(3):2891-2900. PubMed ID: 31602642
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ASC-associated inflammation promotes cecal tumorigenesis in aryl hydrocarbon receptor-deficient mice.
    Ikuta T; Kobayashi Y; Kitazawa M; Shiizaki K; Itano N; Noda T; Pettersson S; Poellinger L; Fujii-Kuriyama Y; Taniguchi S; Kawajiri K
    Carcinogenesis; 2013 Jul; 34(7):1620-7. PubMed ID: 23455376
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MicroRNA-454 inhibits non‑small cell lung cancer cells growth and metastasis via targeting signal transducer and activator of transcription-3.
    Liu S; Ge X; Su L; Zhang A; Mou X
    Mol Med Rep; 2018 Mar; 17(3):3979-3986. PubMed ID: 29286124
    [TBL] [Abstract][Full Text] [Related]  

  • 39. ILT4 inhibition prevents TAM- and dysfunctional T cell-mediated immunosuppression and enhances the efficacy of anti-PD-L1 therapy in NSCLC with EGFR activation.
    Chen X; Gao A; Zhang F; Yang Z; Wang S; Fang Y; Li J; Wang J; Shi W; Wang L; Zheng Y; Sun Y
    Theranostics; 2021; 11(7):3392-3416. PubMed ID: 33537094
    [No Abstract]   [Full Text] [Related]  

  • 40. Aryl hydrocarbon receptor exogenous ligand 3-methylchoranthrene inhibited endometrial cancer cells proliferation.
    Qu XL; Wang SY; Jia YJ; Guan Y
    Eur Rev Med Pharmacol Sci; 2014; 18(8):1269-76. PubMed ID: 24817304
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.